Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
ADNOC Gas Targets Up to $4B Profit in 2026 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
-- Conference Call to Follow at 4:30 p.m. EDT --
HORSHAM, Pa., Feb. 21, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fourth quarter and fiscal 2017 financial results on Thursday, March 8, after the market close. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | ||
| Date: | Thursday, March 8 | |
| Time: | 4:30 pm Eastern Time | |
| Toll Free: | 888-394-8218 | |
| International: | 323-794-2149 | |
| Passcode: | 6380302 | |
| Webcast: | www.strataskinsciences.com |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
| Investor Contacts: | ||
| Frank McCaney, Chief Executive Officer | Bob Yedid, Managing Director | |
| STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC | |
| 215-619-3200 | 646-597-6989 | |
| [email protected] | [email protected] |
